AZD9567 VERSUS PREDNISOLONE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A PHASE 2A, RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP EFFICACY AND SAFETY STUDY

Van Laar, J. M.; Lei, A.; Safy-Khan, M.; Almquist, J.; Astbury, C.; Belvisi, M.; Platt, A.; Prothon, S.; Samuelsson, S.; Svanberg, P.; Keen, C.

doi:https://doi.org/10.1136/annrheumdis-2021-eular.632

AZD9567 VERSUS PREDNISOLONE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A PHASE 2A, RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP EFFICACY AND SAFETY STUDY

DSpace/Manakin Repository

AZD9567 VERSUS PREDNISOLONE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A PHASE 2A, RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP EFFICACY AND SAFETY STUDY

Van Laar, J. M.; Lei, A.; Safy-Khan, M.; Almquist, J.; Astbury, C.; Belvisi, M.; Platt, A.; Prothon, S.; Samuelsson, S.; Svanberg, P.; Keen, C.

(2021) Annals of the Rheumatic Diseases, volume 80, pp. 253 - 254

(Abstract)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

DOI: https://doi.org/10.1136/annrheumdis-2021-eular.632

ISSN: 0003-4967

Publisher: BMJ Publishing Group